Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Return on Equity (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Return on Equity for 15 consecutive years, with 3.48% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 554.0% to 3.48% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3.48% through Dec 2025, down 554.0% year-over-year, with the annual reading at 6.35% for FY2025, 352.0% up from the prior year.
  • Return on Equity for Q4 2025 was 3.48% at Plus Therapeutics, down from 3.44% in the prior quarter.
  • The five-year high for Return on Equity was 3.81% in Q1 2024, with the low at 20.85% in Q4 2023.
  • Average Return on Equity over 5 years is 2.2%, with a median of 1.31% recorded in 2022.
  • The sharpest move saw Return on Equity crashed -1858bps in 2023, then surged 2292bps in 2024.
  • Over 5 years, Return on Equity stood at 0.96% in 2021, then plummeted by -136bps to 2.27% in 2022, then plummeted by -818bps to 20.85% in 2023, then surged by 110bps to 2.07% in 2024, then tumbled by -268bps to 3.48% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 3.48%, 3.44%, and 1.29% for Q4 2025, Q3 2025, and Q2 2025 respectively.